“…Diversely substituted 3,3-diaryloxindole and dibenzo[ b , e ]azepin-6-one scaffolds are potentially useful pharmacophoric constructs that display a broad range of interesting biological activities (Figure ). , For example, 3,3-diarylated-2-oxindole derivatives are known to exhibit anticancer, antioxidant, Ca 2+ -depleting translation initiation inhibitory, and mineralocorticoid receptor antagonist activities among others . On the other hand, dibenzo[ b , e ]azepin-6-one derivatives possess antiulcer, central nervous system (CNS), and anticonvulsant activities .…”